Evolving pancreatic cancer treatment: From diagnosis to healthcare management

Author:

Milella Michele,Bassi Claudio,Boggi UgoORCID,Brunetti Oronzo,Cavaliere AlessandroORCID,Crippa Stefano,De Vita Ferdinando,Falconi Massimo,Frassineti Giovanni Luca,Giommoni Elisa,Macchini MarinaORCID,Malleo Giuseppe,Silvestris Nicola,Tudisco Antonella,Vasile EnricoORCID,Reni Michele

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference206 articles.

1. Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease;Abdel-Misih;Ann. Surg. Oncol.,2011

2. Combined modality treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement;Abrams;Ann. Surg. Oncol.,2009

3. Hepatic resection for non-colorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model;Adam;Ann. Surg.,2006

4. Real-time genomic characterization of advanced pancreatic Cancer to enable precision medicine;Aguirre;Cancer Discov.,2018

5. Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma;Ahola;Br. J. Surg.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3